Journal of Neurophysiology, Vol 61, Issue 4 719-726, Copyright © 1989 by APS

ARTICLES

GABA- and glutamate-mediated synaptic potentials in rat dorsal raphe neurons in vitro

Z. Z. Pan and J. T. Williams
Vollum Institute, Oregon Health Sciences University, Portland 97201.

1. Synaptic potentials were recorded with intracellular electrodes from rat dorsal raphe neurons in a slice preparation. 2. Synaptic potentials were evoked by applying electrical pulses to bipolar stimulating electrodes positioned immediately dorsal to the raphe nucleus; these arose after a latency of 0.5-5 ms and had a duration of 20-200 ms. 3. The synaptic potential was biphasic (at the resting potential) when the recording electrodes contained potassium citrate; a depolarization was followed by a hyperpolarization. The hyperpolarization reversed in polarity at -70 mV and was blocked by bicuculline. 4. The depolarizing synaptic potential was reduced to 50-90% of control by kynurenate (1-2 mM) or 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline (CNQX) (10 microM) and increased in amplitude and duration by magnesium-free solution. 5. In magnesium-free solutions (with CNQX), the depolarizing synaptic potential was blocked by DL-2-amino-5-phosphonovaleric acid (APV, 50 microM). APV also blocked depolarization caused by adding N-methyl-D-aspartate (NMDA) to the superfusion solution. 6. The results indicate that raphe neurons display two synaptic potentials having a duration of 150-200 ms: one that is mediated by GABA and a second that is due to an excitatory amino acid. The component mediated by an excitatory amino acid involves, in part, a receptor of the NMDA type.

This article has been cited by other articles:

				J. D. Glass, G. H. Grossman, L. Farnbauch, and L. DiNardo Midbrain Raphe Modulation of Nonphotic Circadian Clock Resetting and 5-HT Release in the Mammalian Suprachiasmatic Nucleus J. Neurosci., August 20, 2003; 23(20): 7451 - 7460. [Abstract] [Full Text] [PDF]

				P. Celada, M. V. Puig, J. M. Casanovas, G. Guillazo, and F. Artigas Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors J. Neurosci., December 15, 2001; 21(24): 9917 - 9929. [Abstract] [Full Text] [PDF]

				H. Morikawa, O. J. Manzoni, J. C. Crabbe, and J. T. Williams Regulation of Central Synaptic Transmission by 5-HT1B Auto- and Heteroreceptors Mol. Pharmacol., April 13, 2001; 58(6): 1271 - 1278. [Abstract] [Full Text]

				D. Gervasoni, C. Peyron, C. Rampon, B. Barbagli, G. Chouvet, N. Urbain, P. Fort, and P.-H. Luppi Role and Origin of the GABAergic Innervation of Dorsal Raphe Serotonergic Neurons J. Neurosci., June 1, 2000; 20(11): 4217 - 4225. [Abstract] [Full Text] [PDF]

				G. Pineyro and P. Blier Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action Pharmacol. Rev., September 1, 1999; 51(3): 533 - 591. [Abstract] [Full Text] [PDF]

				M. J. Millan, M. Brocco, A. Gobert, R. Schreiber, and A. Dekeyne S-16924 [(R)-2-{1-[2-(2,3-Dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl}-1-(4-fluorophenyl)-ethanone], a Novel, Potential Antipsychotic with Marked Serotonin1A Agonist Properties: III. Anxiolytic Actions in Comparison with Clozapine and Haloperidol J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1002 - 1014. [Abstract] [Full Text]

				X. Li, D. G. Rainnie, R. W. McCarley, and R. W. Greene Presynaptic Nicotinic Receptors Facilitate Monoaminergic Transmission J. Neurosci., March 1, 1998; 18(5): 1904 - 1912. [Abstract] [Full Text] [PDF]

				M. J. Millan, S. Hjorth, R. Samanin, R. Schreiber, R. Jaffard, B. De Ladonchamps, S. Veiga, B. Goument, J.-L. Peglion, M. Spedding, et al. S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 148 - 161. [Abstract] [Full Text]